{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:05:41Z","timestamp":1751256341943,"version":"3.41.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.revmed.2024.11.004","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T12:21:38Z","timestamp":1732191698000},"page":"397-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prise en charge du purpura thrombotique thrombocytop\u00e9nique cong\u00e9nital \u00e0 l\u2019\u00e8re de la prot\u00e9ine ADAMTS13\u00a0recombinante\u00a0: recommandations du Centre de r\u00e9f\u00e9rence des microangiopathies thrombotiques (CNR-MAT)"],"prefix":"10.1016","volume":"46","author":[{"given":"B\u00e9rang\u00e8re S.","family":"Joly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Dossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Gouge-Biebuyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilis","family":"Tsatsaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2024.11.004_bib0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.18632\/oncoscience.380","article-title":"Recombinant ADAMTS 13\u00a0in thrombotic thrombocytopenic purpura","volume":"4","author":"Scully","year":"2017","journal-title":"Oncoscience"},{"key":"10.1016\/j.revmed.2024.11.004_bib0235","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.11.004_bib0240","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0245","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0250","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0255","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.11.004_bib0260","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.11.004_bib0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2024.11.004_bib0270","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13\u00a0deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0275","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1055\/s-0038-1673686","article-title":"ADAMTS13\u00a0Gene Mutations Influence ADAMTS13\u00a0Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome","volume":"118","author":"Joly","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0280","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","article-title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","volume":"104","author":"van Dorland","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2024.11.004_bib0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/bloodadvances.2023011972","article-title":"Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience","volume":"8","author":"B\u00e9ranger","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.11.004_bib0290","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.17560","article-title":"Current prophylactic plasma infusion protocols do not adequately prevent long-term cumulative organ damage in the Japanese congenital thrombotic thrombocytopenic purpura cohort","volume":"194","author":"Sakai","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jth.13186","article-title":"High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence","volume":"14","author":"von Krogh","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0300","doi-asserted-by":"crossref","first-page":"e112935","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"Drury-Stewart","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2024.11.004_bib0305","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1538-7836.2008.02846.x","article-title":"Prevalence of the ADAMTS-13\u00a0missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura","volume":"6","author":"Camilleri","year":"2008","journal-title":"J Thromb Haemost"},{"year":"2023","series-title":"Purpura thrombotique thrombocytop\u00e9nique","key":"10.1016\/j.revmed.2024.11.004_bib0310"},{"key":"10.1016\/j.revmed.2024.11.004_bib0315","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13\u00a0deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2024.11.004_bib0320","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0325","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1055\/a-1378-3804","article-title":"Performance of diagnostic scores in thrombotic microangiopathy patients in the Intensive Care Unit: a monocentric study","volume":"121","author":"Mariotte","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0330","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0335","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mpd.2003.79","article-title":"Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome","volume":"142","author":"Veyradier","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.revmed.2024.11.004_bib0345","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0350","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.19026","article-title":"A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies","volume":"203","author":"Scully","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614408","article-title":"Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura","volume":"81","author":"Furlan","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0360","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0365","first-page":"182","article-title":"Phase 3\u00a0prospective, randomized, controlled, open-label, multicenter, crossover study of recombinant ADAMTS13\u00a0in patients with congenital thrombotic thrombocytopenic purpura (abstract no. OC 14.1)","author":"Scully","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0370","first-page":"183","article-title":"Recombinant ADAMTS13\u00a0prophylaxis in patients with congenital thrombotic thrombocytopenic purpura: interim analysis from phase 3B continuation study [abstract no. OC 14.4]","author":"Coppo","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0375","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jth.14345","article-title":"Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura","volume":"17","author":"Taylor","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.11.004_bib0380","unstructured":"D\u00e9cision no\u00a02024.0032\/DC\/SEM du 8\u00a0f\u00e9vrier 2024\u00a0du coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 portant autorisation d\u2019acc\u00e8s pr\u00e9coce de la sp\u00e9cialit\u00e9 TAK755 (apadamtase alfa) https:\/\/www.has-sante.fr."},{"key":"10.1016\/j.revmed.2024.11.004_bib0385","unstructured":"European Medicines Agency. Adzynma, rADAMTS13; European Commission decision. Adzynma: EPAR - Product information https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/adzynma."},{"key":"10.1016\/j.revmed.2024.11.004_bib0390","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood-2013-04-496752","article-title":"Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura","volume":"122","author":"Deford","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0395","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/bloodadvances.2020004169","article-title":"Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission","volume":"6","author":"Sukumar","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.11.004_bib0400","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2019001056","article-title":"Reduced ADAMTS13\u00a0activity during TTP remission is associated with stroke in TTP survivors","volume":"134","author":"Upreti","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0405","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc23-Sint","article-title":"Introduction and methodology: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2024.11.004_bib0410","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2024.11.004_bib0415","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024\u00a0clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2024.11.004_bib0420","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.24060","article-title":"Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura","volume":"90","author":"Han","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0425","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/trf.14060","article-title":"Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura","volume":"57","author":"Falter","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2024.11.004_bib0430","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.11.004_bib0435","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1002\/ajh.23997","article-title":"Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center","volume":"90","author":"Benhamou","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0440","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jha2.178","article-title":"Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura","volume":"2","author":"Alwan","year":"2021","journal-title":"EJHaem"},{"key":"10.1016\/j.revmed.2024.11.004_bib0445","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/bjh.18651","article-title":"A \u201cneedle in a haystack\u201d: Drug-induced thrombotic thrombocytopenic purpura-Association or causality?","volume":"201","author":"Scully","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2024.11.004_bib0225","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1056\/NEJMoa2211113","article-title":"Recombinant ADAMTS13\u00a0for Hereditary Thrombotic Thrombocytopenic Purpura","volume":"387","author":"Asmis","year":"2022","journal-title":"N Engl J Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324012773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324012773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:36:25Z","timestamp":1751214985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324012773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0248866324012773"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.11.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge du purpura thrombotique thrombocytop\u00e9nique cong\u00e9nital \u00e0 l\u2019\u00e8re de la prot\u00e9ine ADAMTS13\u00a0recombinante\u00a0: recommandations du Centre de r\u00e9f\u00e9rence des microangiopathies thrombotiques (CNR-MAT)","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}